(Q34551348)

3 August 2017

title

Hepatitis C: an epidemiological review (English)

1 reference

3 August 2017

1 reference

1 reference

Memon MI

1

1 reference

3 August 2017

Memon MA

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Journal of Viral Hepatitis

3 August 2017

published in

1 reference

3 August 2017

volume

9

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

84-100

1 reference

publication type of scholarly work

3 August 2017

review article

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiology of Hepatitis C in the West

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus six years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Sequence analysis of the core gene of 14 hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in children with hemophilia: Characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C antibody and chronic liver disease in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C transmission associated with intravenous immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Intravenous immunoglobulin and hepatitis C virus: the Boston episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C infection and viremia in Dutch hemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The natural history of chronic hepatitis C in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

How important is hepatitis C virus (HCV)-infection in persons with acute leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Nosocomial transmission of hepatitis C virus within a British dialysis centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Transmission of hepatitis C virus by a cardiac surgeon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis B and hepatitis C in emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Occupational risk for hepatitis C virus infection among New York City dentists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C antibodies in clinical health-care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C antibodies in health-care workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Low rate of hepatitis C virus (HCV) transmission within the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Anti-HCV antibodies in household contacts of patients with cirrhosis of the liver--preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Intrafamilial spread of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Intrafamilial and sexual transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Horizontal transmission of hepatitis C virus in households of infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus antibodies among risk groups in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Spread of hepatitis C virus infection within families. Investigators of an Italian Multicenter Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in family setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus and sexual transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus: evidence for sexual transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The low efficiency of maternal-neonatal transmission of hepatitis C virus: how certain are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in infants whose mothers took street drugs intravenously

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Mother to infant transmission of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Vertical transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Mother-to-infant transmission of hepatitis C virus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Vertical transmission of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The incidence of vertical transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Failure to detect vertical transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Vertical transmission of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Infrequent vertical transmission of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

A prospective study on mother-to-infant transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Least microtransfusion from mother to fetus in elective cesarean delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus RNA in saliva and breastmilk of hepatitis C carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiology of Hepatitis C in the East

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C infection in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis virus markers in the Baiga tribal population of Madhya Pradesh, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiology of hepatitis C virus infection in an area of Southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Natural horizontal transmission of HCV in microepidemic town in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of Hepatitis C Virus Antibody Among Korean Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Anti-HCV antibody prevalence among an asymptomatic population living in two villages in Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C virus in family members of patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Seroprevalence of hepatitis C antibody in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus antibodies in high-risk Saudi groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Seropositivity to hepatitis C virus in Saudi haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Seroepidemiology of hepatitis C virus infection in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The role of hepatitis C virus in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Seroepidemiology of hepatitis B, C and delta viruses in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Low prevalence of antibody to hepatitis C virus in an urban adolescent population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Low prevalence of hepatitis C virus infection in Lusaka, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis B and C prevalences among blood donors in the south region of Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiological characteristics of the incidence of hepatitis C virus (C100‐3) antibodies in patients with liver diseases in the Inshore Area of the Yangtze River

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus RNA and antibodies among blood donors in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C antibody prevalence in blood donors in different governorates in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The risk of hepatitis C virus infection among blood donors in Osaka, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C virus related to liver diseases in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in the asymptomatic British blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Comparison of two second-generation anti-hepatitis C virus ELISA on 21431 US blood donor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Demographic determinants of hepatitis C virus seroprevalence among blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Porphyria cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: a one-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Occupationally acquired hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: a multiple regression analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Low prevalence of hepatitis C virus infection among hospital staff and acupuncturists in Kyushu, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Frequency of parenteral exposure and seroprevalence of HBV, HCV, and HIV among operation room personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals. Who is at risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Risk factors for hepatitis C virus infection among health care personnel in a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Transmission of Hepatitis C Virus to Sexual Partners of Seropositive Patients with Bleeding Disorders: A Rare Event

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in spouses of patients with type C chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C transmission between spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Transmission of hepatitis C virus to spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The low risk of hepatitis C virus transmission among sexual partners of confirmed HCV-positive blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Intrafamily transmission of hepatitis C virus: sexual and non-sexual contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Sexual and non-sexual intrafamilial spread of hepatitis C virus: intrafamilial transmission of HCV

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of hepatitis C virus infections among heterosexuals with multiple partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in homosexual men: A seroepidemiological study in gay clubs in North-East Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Anti-hepatitis C virus antibodies amongst Italian homo-bisexual males

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in sexually promiscuous groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection in sexually active homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus antibodies in prostitutes in Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Syringe exchange and risk of infection with hepatitis B and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Viral Hepatitis in Health Care Personnel at The Johns Hopkins Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

Chronic hepatitis C after high-dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00329.X

10.1046/J.1365-2893.2002.00329.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference